JAC Advance Access published online on February 10, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki011
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Belgian Reference Centre for Group A Streptococcus, University of Antwerp, Campus Drie Eiken, Antwerpen, Belgium
* To whom correspondence should be addressed. Background: Fluoroquinolones are an important group of antibiotics widely used in adults, and, despite the absence of official approval, these drugs are also used in children. So far, resistance to fluoroquinolones in Streptococcus pyogenes is very rare. Methods: During a national surveillance programme in Belgium from 1999-2002, 2793 non-duplicate S. pyogenes recovered from tonsillopharyngitis patients were screened for fluoroquinolone resistance. Mutations in topoisomerase genes and the presence of any efflux pump activity were investigated to elucidate the fluoroquinolone resistance mechanisms. Clonality was assessed by pulsed-field gel electrophoresis (PFGE) and emm typing. Results: Non-susceptibility to fluoroquinolones, defined as ciprofloxacin MIC Conclusions: We show here, for the first time, a multi-clonal spread of fluoroquinolone non-susceptible S. pyogenes exhibiting a known resistance mechanism. Non-susceptibility to fluoroquinolones in paediatric isolates is of concern.
Received September 20, 2004
Revised December 7, 2004
Accepted December 8, 2004
Original article
Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes
2 Department of Epidemiology and Community Medicine, University of Antwerp, Campus Drie Eiken, Antwerpen, Belgium
Surbhi Malhotra-Kumar, E-mail: surbhi.malhotra{at}ua.ac.be
![]()
Abstract
2 mg/L, was identified in 152 (5.4%) of 2793 S. pyogenes. Fifty-five (36%) fluoroquinolone non-susceptible isolates were investigated for known resistance mechanisms; all showed mutations in parC, and 29 (19%) isolates also in parE; antibiotic efflux was not noted. Two major PFGE types comprised 88% of fluoroquinolone non-susceptible S. pyogenes and belonged to serotypes emm6 and emm75. Overall, emm6 and emm75 constituted >90% of all fluoroquinolone non-susceptible isolates and showed a significant temporal and geographical shift within Belgian provinces. Although fluoroquinolone-susceptible S. pyogenes also showed fluctuations in the predominant S. pyogenes serotypes, emm6 or emm75 were under-represented in this population. Approx. 55% of the fluoroquinolone non-susceptible isolates were recovered from children (
16 years).![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Malhotra-Kumar, L. Van Heirstraeten, C. Lammens, S. Chapelle, and H. Goossens Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin J. Antimicrob. Chemother., May 1, 2009; 63(5): 886 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Duesberg, S. Malhotra-Kumar, H. Goossens, L. McGee, K. P. Klugman, T. Welte, and M. W. R. Pletz Interspecies Recombination Occurs Frequently in Quinolone Resistance-Determining Regions of Clinical Isolates of Streptococcus pyogenes Antimicrob. Agents Chemother., November 1, 2008; 52(11): 4191 - 4193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wajima, S. Y. Murayama, K. Sunaoshi, E. Nakayama, K. Sunakawa, and K. Ubukata Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease J. Med. Microbiol., November 1, 2008; 57(11): 1383 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Meisal, E. A. Hoiby, I. S. Aaberge, and D. A. Caugant Sequence Type and emm Type Diversity in Streptococcus pyogenes Isolates Causing Invasive Disease in Norway between 1988 and 2003 J. Clin. Microbiol., June 1, 2008; 46(6): 2102 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Wu, R. P. Janapatla, Y.-R. Ho, K.-H. Hung, C.-W. Wu, J.-J. Yan, and J.-J. Wu Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in Taiwan Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1888 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Billal, D. P. Fedorko, S. S. Yan, M. Hotomi, K. Fujihara, N. Nelson, and N. Yamanaka In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types J. Antimicrob. Chemother., January 1, 2007; 59(1): 28 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rivera, M. Rebollo, E. Miro, M. Mateo, F. Navarro, M. Gurgui, B. Mirelis, and P. Coll Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. R. Pletz, L. McGee, C. A. Van Beneden, S. Petit, M. Bardsley, M. Barlow, and K. P. Klugman Fluoroquinolone Resistance in Invasive Streptococcus pyogenes Isolates Due to Spontaneous Mutation and Horizontal Gene Transfer Antimicrob. Agents Chemother., March 1, 2006; 50(3): 943 - 948. [Abstract] [Full Text] [PDF] |
||||



